10-K/A: Annual report (Amendment)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Latest
16:33
JUNSHI BIO: The clinical trial application for injectable JS212 has been accepted.
JUNSHI BIO-3.05%
16:31
In December, RONSHINECHINA's contracted sales amount to 0.7707 billion yuan, with a cumulative contracted sales amount of 7.7 billion yuan from January to December.
RONSHINECHINA-4.76%
16:31
Zuckerberg shows goodwill to the Trump administration as Meta platforms terminate the fact-checking project.
META-1.95%